Europe
Pharma and life sciences companies from across the globe provide updates on their pipelines and business practices.
BioSpace takes a quick look at some recent, key industry news that is not related to the coronavirus.
A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.
“The industry is increasing capacities, but at the same time infection rates are even increasing faster,” said Roche CEO Severin Schwan. “At the moment, capacities are limited. That is why we have to prioritize testing to higher risk patients.”
A summary of daily biopharma industry news. Please check out stories that are trending on March 24, 2020.
Europe’s new pharmaceutical roadmap is designed to reinvigorate innovation in the pharmaceutical industry to make it competitive with the United States.
“Using untested drugs without the right evidence could raise false hope and even do more harm than good and cause a shortage of essential drugs that are needed to treat other diseases,” said WHO Director-General Tedros Adhanom Ghebreyesus.
Malaria Drug and Antibiotic Combo May Work Against COVID-19, But Experts Warn Caution and Skepticism
French researchers have published an article describing the potential use of a combination of hydroxychloroquine and the antibiotic azithromycin. The U.S. Food and Drug Administration is also evaluating the drugs but have not yet made recommendations.
The U.S. Food and Drug Administration issued a Completed Response Letter of Eli Lilly and Company and Boehringer Ingelheim’s Jardiance (empaglifozin) for type 1 diabetes.
A summary of daily biopharma industry news. Please check out stories that are trending on March 23, 2020.
PRESS RELEASES